指南&解读指南

订阅

MedSci主页 / 所有栏目 / 指南&解读指南

2016 台湾心房颤动管理指南

2016-11-30

心房颤动

2016年11月，台湾心率学会(Taiwan Heart Rhythm Society)联合台湾心脏病学会(TSOC)共同发布了心房颤动管理指南。

中文标题：

2016 台湾心房颤动管理指南

英文标题：

2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation.

发布机构：

发布日期：

2016-11-30

简要介绍：

2016年11月，台湾心率学会(Taiwan Heart Rhythm Society)联合台湾心脏病学会(TSOC)共同发布了心房颤动管理指南。指南主要基于亚洲人的特点提出了房颤管理的更新建议，主要内容包括房颤的流行病学，发病机制和病理生理，房颤并发症，房颤患者的结局，临床表现，分类，诊断评估，治疗，卒中预防，速度和节律的控制，射频消融治疗。 拓展指南：与心房颤动相关指南：


制定者：

台湾心率学会(Taiwan Heart Rhythm Society)
台湾心脏病学会(TSOC,Taiwan Society of Cardiology)

相关资料下载：
[AttachmentFileName(sort=100, fileName=2016 台湾心房颤动管理指南)] GetToolGuiderByIdResponse(projectId=1, id=d2fd31c00133e120, title=2016 台湾心房颤动管理指南, enTitle=2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation., guiderFrom=, authorId=null, author=, summary=2016年11月，台湾心率学会(Taiwan Heart Rhythm Society)联合台湾心脏病学会(TSOC)共同发布了心房颤动管理指南。, cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Wed Nov 30 11:17:04 CST 2016, originalUrl=, linkOutUrl=, content=<span style="text-indent: 28px;">2016年11月，台湾心率学会(Taiwan Heart Rhythm Society)联合台湾心脏病学会(TSOC)共同发布了心房颤动管理指南。指南主要基于亚洲人的特点提出了房颤管理的更新建议，主要内容包括房颤的流行病学，发病机制和病理生理，房颤并发症，房颤患者的结局，临床表现，分类，诊断评估，治疗，卒中预防，速度和节律的控制，射频消融治疗。</span> 拓展指南：<strong>与<font color=red>心房颤动</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=8ed5f1c00132160a" title="2016 老年人非瓣膜性心房颤动诊治中国专家建议" target=_blank>2016 老年人非瓣膜性心房颤动诊治中国专家建议</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=78d1c1c0011323b0" title="2014 左心耳干预预防心房颤动患者血栓栓塞事件：目前的认识和建议" target=_blank>2014 左心耳干预预防心房颤动患者血栓栓塞事件：目前的认识和建议</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=66bd61c0010952e7" title="2014 缺血性卒中/短暂性脑缺血发作患者合并心房颤动的筛查及抗栓治疗中国专家共识" target=_blank>2014 缺血性卒中/短暂性脑缺血发作患者合并心房颤动的筛查及抗栓治疗中国专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=061c31c0010821e0" title="2014 NICE：心房颤动管理临床指南( CG180)" target=_blank>2014 NICE：心房颤动管理临床指南( CG180)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=342cf1c0010e79dd" title="2014 非瓣膜病心房颤动患者应用新型口服抗凝药物中国专家建议" target=_blank>2014 非瓣膜病心房颤动患者应用新型口服抗凝药物中国专家建议</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E5%BF%83%E6%88%BF%E9%A2%A4%E5%8A%A8" target=_blank>有关心房颤动更多指南</a></ul><div><br></div><div><div><span style="font-weight: bold;">制定者：</span></div><div><span style="font-weight: bold;"><br></span></div><div>台湾心率学会(Taiwan Heart Rhythm Society)</div><div>台湾心脏病学会(TSOC,Taiwan Society of Cardiology)</div></div>, tagList=[TagDto(tagId=367, tagName=心房颤动)], categoryList=[CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4238, appHits=329, showAppHits=0, pcHits=2658, showPcHits=1560, likes=146, shares=5, comments=7, approvalStatus=1, publishedTime=Wed Nov 30 11:17:04 CST 2016, publishedTimeString=2016-11-30, pcVisible=1, appVisible=1, editorId=88252, editor=jingwen, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=jingwen, createdTime=Wed Nov 30 11:17:04 CST 2016, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 07:44:16 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016 台湾心房颤动管理指南)])
2016 台湾心房颤动管理指南
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1057160, encodeId=52a5105e1609f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 16:31:04 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947798, encodeId=c09994e79845, content=很好的文章。很有受益。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77412454510, createdName=12400507m54暂无昵称, createdTime=Sat Mar 13 07:39:30 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160225, encodeId=fd271602259d, content=谢谢共享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/IgQVNoW5cFSgnREl4xSltTx9aCZ5QYxQnqcJgSduAAkRluhMSUuapklqicw0giaVFXPYAfEvmQW0CZiabZuwNiaNFw/0, createdBy=d5701970501, createdName=mimangzhe, createdTime=Sun Dec 04 17:32:05 CST 2016, time=2016-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160123, encodeId=462616012373, content=谢谢分享，要好好学习的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/31/60fc0213ae09a3dbbba19993663ef4db.jpg, createdBy=33c31971480, createdName=1e160a78m83(暂无匿称), createdTime=Sun Dec 04 08:59:41 CST 2016, time=2016-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159466, encodeId=525d159466e9, content=谢谢你们的分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86211736158, createdName=奋斗目标管理责任, createdTime=Thu Dec 01 17:00:24 CST 2016, time=2016-12-01, status=1, ipAttribution=)]
    2021-10-03 H8888888

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1057160, encodeId=52a5105e1609f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 16:31:04 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947798, encodeId=c09994e79845, content=很好的文章。很有受益。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77412454510, createdName=12400507m54暂无昵称, createdTime=Sat Mar 13 07:39:30 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160225, encodeId=fd271602259d, content=谢谢共享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/IgQVNoW5cFSgnREl4xSltTx9aCZ5QYxQnqcJgSduAAkRluhMSUuapklqicw0giaVFXPYAfEvmQW0CZiabZuwNiaNFw/0, createdBy=d5701970501, createdName=mimangzhe, createdTime=Sun Dec 04 17:32:05 CST 2016, time=2016-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160123, encodeId=462616012373, content=谢谢分享，要好好学习的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/31/60fc0213ae09a3dbbba19993663ef4db.jpg, createdBy=33c31971480, createdName=1e160a78m83(暂无匿称), createdTime=Sun Dec 04 08:59:41 CST 2016, time=2016-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159466, encodeId=525d159466e9, content=谢谢你们的分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86211736158, createdName=奋斗目标管理责任, createdTime=Thu Dec 01 17:00:24 CST 2016, time=2016-12-01, status=1, ipAttribution=)]
    2021-03-13 12400507m54暂无昵称

    很好的文章。很有受益。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1057160, encodeId=52a5105e1609f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 16:31:04 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947798, encodeId=c09994e79845, content=很好的文章。很有受益。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77412454510, createdName=12400507m54暂无昵称, createdTime=Sat Mar 13 07:39:30 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160225, encodeId=fd271602259d, content=谢谢共享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/IgQVNoW5cFSgnREl4xSltTx9aCZ5QYxQnqcJgSduAAkRluhMSUuapklqicw0giaVFXPYAfEvmQW0CZiabZuwNiaNFw/0, createdBy=d5701970501, createdName=mimangzhe, createdTime=Sun Dec 04 17:32:05 CST 2016, time=2016-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160123, encodeId=462616012373, content=谢谢分享，要好好学习的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/31/60fc0213ae09a3dbbba19993663ef4db.jpg, createdBy=33c31971480, createdName=1e160a78m83(暂无匿称), createdTime=Sun Dec 04 08:59:41 CST 2016, time=2016-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159466, encodeId=525d159466e9, content=谢谢你们的分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86211736158, createdName=奋斗目标管理责任, createdTime=Thu Dec 01 17:00:24 CST 2016, time=2016-12-01, status=1, ipAttribution=)]
    2016-12-04 mimangzhe

    谢谢共享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1057160, encodeId=52a5105e1609f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 16:31:04 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947798, encodeId=c09994e79845, content=很好的文章。很有受益。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77412454510, createdName=12400507m54暂无昵称, createdTime=Sat Mar 13 07:39:30 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160225, encodeId=fd271602259d, content=谢谢共享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/IgQVNoW5cFSgnREl4xSltTx9aCZ5QYxQnqcJgSduAAkRluhMSUuapklqicw0giaVFXPYAfEvmQW0CZiabZuwNiaNFw/0, createdBy=d5701970501, createdName=mimangzhe, createdTime=Sun Dec 04 17:32:05 CST 2016, time=2016-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160123, encodeId=462616012373, content=谢谢分享，要好好学习的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/31/60fc0213ae09a3dbbba19993663ef4db.jpg, createdBy=33c31971480, createdName=1e160a78m83(暂无匿称), createdTime=Sun Dec 04 08:59:41 CST 2016, time=2016-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159466, encodeId=525d159466e9, content=谢谢你们的分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86211736158, createdName=奋斗目标管理责任, createdTime=Thu Dec 01 17:00:24 CST 2016, time=2016-12-01, status=1, ipAttribution=)]
    2016-12-04 1e160a78m83(暂无匿称)

    谢谢分享，要好好学习的

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1057160, encodeId=52a5105e1609f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 16:31:04 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947798, encodeId=c09994e79845, content=很好的文章。很有受益。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77412454510, createdName=12400507m54暂无昵称, createdTime=Sat Mar 13 07:39:30 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160225, encodeId=fd271602259d, content=谢谢共享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/IgQVNoW5cFSgnREl4xSltTx9aCZ5QYxQnqcJgSduAAkRluhMSUuapklqicw0giaVFXPYAfEvmQW0CZiabZuwNiaNFw/0, createdBy=d5701970501, createdName=mimangzhe, createdTime=Sun Dec 04 17:32:05 CST 2016, time=2016-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160123, encodeId=462616012373, content=谢谢分享，要好好学习的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/31/60fc0213ae09a3dbbba19993663ef4db.jpg, createdBy=33c31971480, createdName=1e160a78m83(暂无匿称), createdTime=Sun Dec 04 08:59:41 CST 2016, time=2016-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159466, encodeId=525d159466e9, content=谢谢你们的分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86211736158, createdName=奋斗目标管理责任, createdTime=Thu Dec 01 17:00:24 CST 2016, time=2016-12-01, status=1, ipAttribution=)]
    2016-12-01 奋斗目标管理责任

    谢谢你们的分享

    0